Perspective Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Perspective Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Perspective Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 70.6M shares, a 152% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 268M shares, a 88.4% increase from 2022.
  • Perspective Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 142M shares, a 36.8% increase from 2021.
  • Perspective Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 104M shares, a 53.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 70.6M +42.6M +152% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 66.6M +38.6M +138% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 495M +267M +117% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 268M +126M +88.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 28.1M -114M -80.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 28M -114M -80.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 229M +86.6M +60.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 142M +112K +0.08% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 142M +157K +0.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 142M +367K +0.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 142M +19.5M +15.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 142M +58.9M +70.9% Oct 1, 2021 Dec 31, 2021 10-K 2022-09-28
Q3 2021 142M +73M +106% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 142M Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 123M Jan 1, 2021 Mar 31, 2021 10-K 2022-09-28
Q4 2020 83M Oct 1, 2020 Dec 31, 2020 10-K 2022-09-28
Q3 2020 68.9M Jul 1, 2020 Sep 30, 2020 10-K 2022-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.